Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report a case of seized crystalline methamphetamine (MA) samples showing unique drug profiles. The samples were mainly composed of (S)-(+)-MA, with each containing a slight amount of (R)-(-)-MA (enantiomeric excess: 99.2-99.4%). 1-Phenyl-2-propanol and
N-methyl-2-phenylacetamide
were detected as characteristic impurities. These analytical results suggested that the samples were synthesized as racemic MA by reductive amination of 1-phenyl-2-propanone, which was synthesized from phenylacetic acid, putatively prepared from phenylacetic acid ester, and then the racemic MA was optically resolved to the (+)-form-rich product. This proposed preparation route was in accordance with recent reports of
seizures
worldwide of the raw materials of MA such as phenylacetic acid derivatives, methylamine, and tartaric acid (optical resolving reagent).
...
PMID:Chemical profiling of seized methamphetamine putatively synthesized from phenylacetic acid derivatives. 2298 1